198 related articles for article (PubMed ID: 7803787)
1. Characterization of three erythropoietin (Epo)-binding proteins in various human Epo-responsive cell lines and in cells transfected with human Epo-receptor cDNA.
Takahashi T; Chiba S; Hirano N; Yazaki Y; Hirai H
Blood; 1995 Jan; 85(1):106-14. PubMed ID: 7803787
[TBL] [Abstract][Full Text] [Related]
2. Subunit structure of the erythropoietin receptor analyzed by 125I-Epo cross-linking in cells expressing wild-type or mutant receptors.
Miura O; Ihle JN
Blood; 1993 Apr; 81(7):1739-44. PubMed ID: 8461460
[TBL] [Abstract][Full Text] [Related]
3. A translocated erythropoietin receptor gene in a human erythroleukemia cell line (TF-1) expresses an abnormal transcript and a truncated protein.
Winkelmann JC; Ward J; Mayeux P; Lacombe C; Schimmenti L; Jenkins RB
Blood; 1995 Jan; 85(1):179-85. PubMed ID: 7803793
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the erythropoietin receptor gene in patients with myeloproliferative and myelodysplastic syndromes.
Mittelman M; Gardyn J; Carmel M; Malovani H; Barak Y; Nir U
Leuk Res; 1996 Jun; 20(6):459-66. PubMed ID: 8709617
[TBL] [Abstract][Full Text] [Related]
5. The human erythropoietin receptor.
Winkelmann JC
Int J Cell Cloning; 1992 Sep; 10(5):254-61. PubMed ID: 1453011
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites.
Yi T; Zhang J; Miura O; Ihle JN
Blood; 1995 Jan; 85(1):87-95. PubMed ID: 7528577
[TBL] [Abstract][Full Text] [Related]
7. Production and processing of erythropoietin receptor transcripts in brain.
Chin K; Yu X; Beleslin-Cokic B; Liu C; Shen K; Mohrenweiser HW; Noguchi CT
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):29-42. PubMed ID: 11000476
[TBL] [Abstract][Full Text] [Related]
8. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
9. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
Migliaccio AR; Migliaccio G; D'Andrea A; Baiocchi M; Crotta S; Nicolis S; Ottolenghi S; Adamson JW
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11086-90. PubMed ID: 1722318
[TBL] [Abstract][Full Text] [Related]
10. RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.
Paragh G; Kumar SM; Rakosy Z; Choi SC; Xu X; Acs G
Am J Pathol; 2009 Apr; 174(4):1504-14. PubMed ID: 19264915
[TBL] [Abstract][Full Text] [Related]
11. Lack of functional erythropoietin receptors of cancer cell lines.
Laugsch M; Metzen E; Svensson T; Depping R; Jelkmann W
Int J Cancer; 2008 Mar; 122(5):1005-11. PubMed ID: 17990315
[TBL] [Abstract][Full Text] [Related]
12. The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation.
Sawyer ST; Hankins WD
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6849-53. PubMed ID: 8341708
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
14. In vitro phosphorylation of the erythropoietin receptor and an associated protein, pp130.
Yoshimura A; Lodish HF
Mol Cell Biol; 1992 Feb; 12(2):706-15. PubMed ID: 1310150
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.
Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G
J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518
[TBL] [Abstract][Full Text] [Related]
16. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
17. Identification of a critical ligand binding determinant of the human erythropoietin receptor. Evidence for common ligand binding motifs in the cytokine receptor family.
Middleton SA; Johnson DL; Jin R; McMahon FJ; Collins A; Tullai J; Gruninger RH; Jolliffe LK; Mulcahy LS
J Biol Chem; 1996 Jun; 271(24):14045-54. PubMed ID: 8662939
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the structure of the erythropoietin receptor by ligand blotting.
Atkins HL; Broudy VC; Papayannopoulou T
Blood; 1991 Jun; 77(12):2577-82. PubMed ID: 1646043
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
20. N-glycosylation-defective receptor for erythropoietin can transduce the ligand-induced cell proliferation signal.
Nagao M; Morishita E; Hanai Y; Kobayashi K; Sasaki R
FEBS Lett; 1995 Oct; 373(3):225-8. PubMed ID: 7589471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
